0
     

Report Added
Report already added
Autoimmune Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

Autoimmune Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Autoimmune Disease Therapeutics in Global, including the following market information:

Global Autoimmune Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Autoimmune Disease Therapeutics market was valued at 101010 million in 2021 and is projected to reach US$ 118410 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunosuppressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disease Therapeutics include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autoimmune Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Autoimmune Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Autoimmune Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Others
Global Autoimmune Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Autoimmune Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Independent Pharmacies
Others
Global Autoimmune Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Autoimmune Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Autoimmune Disease Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer
F. Hoffmann-La Roche
Eli Lilly and Company
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Autoimmune Disease Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autoimmune Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Disease Therapeutics Overall Market Size
2.1 Global Autoimmune Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Autoimmune Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autoimmune Disease Therapeutics Players in Global Market
3.2 Top Global Autoimmune Disease Therapeutics Companies Ranked by Revenue
3.3 Global Autoimmune Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Autoimmune Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Disease Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Autoimmune Disease Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Disease Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Autoimmune Disease Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Immunosuppressants
4.1.3 Anti-Inflammatory Drugs
4.1.4 Corticosteroids
4.1.5 Nonsteroidal Anti-inflammatory Drugs
4.1.6 Biologics
4.1.7 Others
4.2 By Type - Global Autoimmune Disease Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Autoimmune Disease Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Autoimmune Disease Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autoimmune Disease Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Independent Pharmacies
5.1.5 Others
5.2 By Application - Global Autoimmune Disease Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Autoimmune Disease Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Autoimmune Disease Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Autoimmune Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Autoimmune Disease Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Autoimmune Disease Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Autoimmune Disease Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Autoimmune Disease Therapeutics Revenue, 2017-2028
6.3.2 US Autoimmune Disease Therapeutics Market Size, 2017-2028
6.3.3 Canada Autoimmune Disease Therapeutics Market Size, 2017-2028
6.3.4 Mexico Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Autoimmune Disease Therapeutics Revenue, 2017-2028
6.4.2 Germany Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4.3 France Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4.4 U.K. Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4.5 Italy Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4.6 Russia Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Autoimmune Disease Therapeutics Market Size, 2017-2028
6.4.8 Benelux Autoimmune Disease Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Autoimmune Disease Therapeutics Revenue, 2017-2028
6.5.2 China Autoimmune Disease Therapeutics Market Size, 2017-2028
6.5.3 Japan Autoimmune Disease Therapeutics Market Size, 2017-2028
6.5.4 South Korea Autoimmune Disease Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Autoimmune Disease Therapeutics Market Size, 2017-2028
6.5.6 India Autoimmune Disease Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Autoimmune Disease Therapeutics Revenue, 2017-2028
6.6.2 Brazil Autoimmune Disease Therapeutics Market Size, 2017-2028
6.6.3 Argentina Autoimmune Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autoimmune Disease Therapeutics Revenue, 2017-2028
6.7.2 Turkey Autoimmune Disease Therapeutics Market Size, 2017-2028
6.7.3 Israel Autoimmune Disease Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Autoimmune Disease Therapeutics Market Size, 2017-2028
6.7.5 UAE Autoimmune Disease Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Autoimmune Disease Therapeutics Major Product Offerings
7.1.4 Pfizer Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Autoimmune Disease Therapeutics Major Product Offerings
7.2.4 Novartis Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Johnson & Johnson Services
7.3.1 Johnson & Johnson Services Corporate Summary
7.3.2 Johnson & Johnson Services Business Overview
7.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Major Product Offerings
7.3.4 Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Services Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Autoimmune Disease Therapeutics Major Product Offerings
7.4.4 Merck Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Autoimmune Disease Therapeutics Major Product Offerings
7.5.4 Sanofi Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Sanofi Key News
7.6 Abott
7.6.1 Abott Corporate Summary
7.6.2 Abott Business Overview
7.6.3 Abott Autoimmune Disease Therapeutics Major Product Offerings
7.6.4 Abott Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Abott Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Major Product Offerings
7.7.4 Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Amgen
7.8.1 Amgen Corporate Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Autoimmune Disease Therapeutics Major Product Offerings
7.8.4 Amgen Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Amgen Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Autoimmune Disease Therapeutics Major Product Offerings
7.9.4 Bayer Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Bayer Key News
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Corporate Summary
7.10.2 F. Hoffmann-La Roche Business Overview
7.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Major Product Offerings
7.10.4 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.10.5 F. Hoffmann-La Roche Key News
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Corporate Summary
7.11.2 Eli Lilly and Company Business Overview
7.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Major Product Offerings
7.11.4 Eli Lilly and Company Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Eli Lilly and Company Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Autoimmune Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Autoimmune Disease Therapeutics Market Drivers in Global Market
Table 3. Autoimmune Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Autoimmune Disease Therapeutics in Global Market
Table 5. Top Autoimmune Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Autoimmune Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Autoimmune Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Autoimmune Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Autoimmune Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Autoimmune Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Autoimmune Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Autoimmune Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Autoimmune Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Autoimmune Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Autoimmune Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Autoimmune Disease Therapeutics Product Offerings
Table 32. Pfizer Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Autoimmune Disease Therapeutics Product Offerings
Table 35. Novartis Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services Corporate Summary
Table 37. Johnson & Johnson Services Autoimmune Disease Therapeutics Product Offerings
Table 38. Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Autoimmune Disease Therapeutics Product Offerings
Table 41. Merck Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Autoimmune Disease Therapeutics Product Offerings
Table 44. Sanofi Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Abott Corporate Summary
Table 46. Abott Autoimmune Disease Therapeutics Product Offerings
Table 47. Abott Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product Offerings
Table 50. Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Amgen Corporate Summary
Table 52. Amgen Autoimmune Disease Therapeutics Product Offerings
Table 53. Amgen Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Autoimmune Disease Therapeutics Product Offerings
Table 56. Bayer Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. F. Hoffmann-La Roche Corporate Summary
Table 58. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product Offerings
Table 59. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Eli Lilly and Company Corporate Summary
Table 61. Eli Lilly and Company Autoimmune Disease Therapeutics Product Offerings
Table 62. Eli Lilly and Company Autoimmune Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Autoimmune Disease Therapeutics Segment by Type in 2021
Figure 2. Autoimmune Disease Therapeutics Segment by Application in 2021
Figure 3. Global Autoimmune Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autoimmune Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autoimmune Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Autoimmune Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abott Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Eli Lilly and Company Autoimmune Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Autoimmune Disease Therapeutics Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW